Lactoferricin Research for Cancer
An evidence-based overview of research examining Lactoferricin in the context of cancer. This page synthesizes findings from peer-reviewed literature.
Research Summary
In vitro studies suggest selective cytotoxicity against cancer cells while sparing normal cells. Mader et al. (2005) demonstrated apoptosis induction in leukemia cells via ROS generation. Cancer cells with exposed phosphatidylserine may be selectively targeted. All evidence is preclinical with no human trials.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Cancer
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Lactoferricin has not received regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.